by Dylan Berman | Apr 20, 2026 | General
Clearmind Medicine Inc. (NASDAQ:CMND) shares are trading higher Monday after the company announced that CMND-100 met the primary endpoint in its FDA-approved Phase I/IIa clinical trial. Clearmind stock is showing exceptional strength. What’s driving CMND stock higher?...
by Anusuya Lahiri | Apr 20, 2026 | General
Guggenheim’s Michael Morris says Netflix Inc. (NASDAQ:NFLX) remains a Buy despite a guidance miss, citing strong long-term growth and valuation support. Valuation And Expectations Drive Near-Term Reaction Michael Morris told CNBC last Friday that the stock remains...
by Parshwa Turakhiya | Apr 20, 2026 | General
Strategy Inc. (NASDAQ:MSTR) has purchased of 34,164 Bitcoin (CRYPTO: BTC) for $2.54 billion at an average price of $74,395 between April 13 and April 19. The Third-Largest Purchase Strategy’s latest acquisition brings total holdings to 815,061 BTC, acquired for...
by Benzinga Insights | Apr 20, 2026 | General
Cleveland-Cliffs (NYSE:CLF) released first-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit...
by Henry Khederian | Apr 20, 2026 | General
Sidus Space Inc (NASDAQ:SIDU) shares are trading lower Monday morning following the company’s announcement of a $58.5 million registered direct offering. Here’s what investors need to know. Sidus Space shares are retreating from recent levels. What’s behind SIDU...
by Dylan Berman | Apr 20, 2026 | General
Nektar Therapeutics (NASDAQ:NKTR) shares are trading higher Monday after the company announced results from a blinded 16-week treatment extension period in its Phase 2b REZOLVE-AA study. Nektar stock is approaching key resistance levels. Why are NKTR shares at highs?...
Recent Comments